RxDoctor Payments DataLook up a doctor →

Paul Singh, MD

Physical Medicine & Rehabilitation · Rockingham, NCNPI 1043221328

Payments from drug & device makers

$11,733in general payments, 2019–2025

Across 307 payments — averaging $38.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$3K
  • Imperative Care, Inc$2K
  • Biotronik NRO, Inc.$2K
  • Boston Scientific$1K
  • Medtronic$785
  • Scilex Pharmaceuticals Inc.$544
  • plus $3K from 38 others

What the payments were for

  • Speaking & faculty fees$2,60022%
  • Travel & lodging$1,68414%
  • Food & beverage$7,40763%
  • Education$420%
  • Gifts$00%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,733 in reported general payments places this provider in the 90th percentile of 269 physical medicine & rehabilitation providers in North Carolina.

See all physical medicine & rehabilitation providers in North Carolina

Medicare billing

Part B allowed, 2024
$741,919
Medicare patients
1,101
Services billed
9,164

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ZtlidoLidocaine57$55,368
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen854$50,854
BelbucaBuprenorphine Hcl38$28,433
OxycontinOxycodone Hcl31$16,609
Buprenorphine62$15,849
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen577$15,011
Xtampza ErOxycodone Myristate30$14,891
Lidocaine74$12,791
Oxycodone Hcl617$12,000
LinzessLinaclotide19$10,138
SymproicNaldemedine Tosylate20$8,998
Gabapentin662$7,606
MovantikNaloxegol Oxalate16$6,380
Pregabalin211$3,000
Fentanyl28$2,587

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Scilex Pharmaceuticals Inc.Ztlido$544$55,36857 claims
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$410$43,32468 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate$56$16,30884 claims
AbbVieLinzess$86$10,13819 claims
Shionogi IncSymproic$20$8,99820 claims
Redhill Biopharma Inc.Movantik$18$6,38016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 269 physical medicine & rehabilitation providers in North Carolina.

Other physical medicine & rehabilitation in Rockingham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →